132 related articles for article (PubMed ID: 15749868)
1. Opposing roles for the cyclin-dependent kinase inhibitor p27kip1 in the control of CD4+ T cell proliferation and effector function.
Rowell EA; Walsh MC; Wells AD
J Immunol; 2005 Mar; 174(6):3359-68. PubMed ID: 15749868
[TBL] [Abstract][Full Text] [Related]
2. T cell effector function and anergy avoidance are quantitatively linked to cell division.
Wells AD; Walsh MC; Sankaran D; Turka LA
J Immunol; 2000 Sep; 165(5):2432-43. PubMed ID: 10946268
[TBL] [Abstract][Full Text] [Related]
3. Cutting edge: p27Kip1 deficiency reduces the requirement for CD28-mediated costimulation in naive CD8+ but not CD4+ T lymphocytes.
Wolfraim LA; Letterio JJ
J Immunol; 2005 Mar; 174(5):2481-4. PubMed ID: 15728451
[TBL] [Abstract][Full Text] [Related]
4. Signaling through CD28 and CTLA-4 controls two distinct forms of T cell anergy.
Wells AD; Walsh MC; Bluestone JA; Turka LA
J Clin Invest; 2001 Sep; 108(6):895-903. PubMed ID: 11560959
[TBL] [Abstract][Full Text] [Related]
5. The cyclin-dependent kinase inhibitor p27kip1 is required for transplantation tolerance induced by costimulatory blockade.
Rowell EA; Wang L; Hancock WW; Wells AD
J Immunol; 2006 Oct; 177(8):5169-76. PubMed ID: 17015702
[TBL] [Abstract][Full Text] [Related]
6. CD28 costimulation mediates down-regulation of p27kip1 and cell cycle progression by activation of the PI3K/PKB signaling pathway in primary human T cells.
Appleman LJ; van Puijenbroek AA; Shu KM; Nadler LM; Boussiotis VA
J Immunol; 2002 Mar; 168(6):2729-36. PubMed ID: 11884439
[TBL] [Abstract][Full Text] [Related]
7. CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression.
Appleman LJ; Berezovskaya A; Grass I; Boussiotis VA
J Immunol; 2000 Jan; 164(1):144-51. PubMed ID: 10605005
[TBL] [Abstract][Full Text] [Related]
8. T cell hyporesponsiveness induced by oral administration of ovalbumin is associated with impaired NFAT nuclear translocation and p27kip1 degradation.
Asai K; Hachimura S; Kimura M; Toraya T; Yamashita M; Nakayama T; Kaminogawa S
J Immunol; 2002 Nov; 169(9):4723-31. PubMed ID: 12391180
[TBL] [Abstract][Full Text] [Related]
9. Helper T cell anergy: from biochemistry to cancer pathophysiology and therapeutics.
Appleman LJ; Tzachanis D; Grader-Beck T; van Puijenbroek AA; Boussiotis VA
J Mol Med (Berl); 2001; 78(12):673-83. PubMed ID: 11434720
[TBL] [Abstract][Full Text] [Related]
10. Cytokine-stimulated T lymphocyte proliferation is regulated by p27Kip1.
Zhang S; Lawless VA; Kaplan MH
J Immunol; 2000 Dec; 165(11):6270-7. PubMed ID: 11086062
[TBL] [Abstract][Full Text] [Related]
11. Suppressor activity of anergic T cells induced by IL-10-treated human dendritic cells: association with IL-2- and CTLA-4-dependent G1 arrest of the cell cycle regulated by p27Kip1.
Kubsch S; Graulich E; Knop J; Steinbrink K
Eur J Immunol; 2003 Jul; 33(7):1988-97. PubMed ID: 12884865
[TBL] [Abstract][Full Text] [Related]
12. CD4+CD25+ regulatory T-cell lines from human cord blood have functional and molecular properties of T-cell anergy.
Li L; Godfrey WR; Porter SB; Ge Y; June CH; Blazar BR; Boussiotis VA
Blood; 2005 Nov; 106(9):3068-73. PubMed ID: 16020508
[TBL] [Abstract][Full Text] [Related]
13. The ability of antigen, but not interleukin-2, to promote n-butyrate-induced T helper 1 cell anergy is associated with increased expression and altered association patterns of cyclin-dependent kinase inhibitors.
Jackson SK; DeLoose A; Gilbert KM
Immunology; 2002 Aug; 106(4):486-95. PubMed ID: 12153511
[TBL] [Abstract][Full Text] [Related]
14. CD28 induces cell cycle progression by IL-2-independent down-regulation of p27kip1 expression in human peripheral T lymphocytes.
Boonen GJ; van Dijk AM; Verdonck LF; van Lier RA; Rijksen G; Medema RH
Eur J Immunol; 1999 Mar; 29(3):789-98. PubMed ID: 10092081
[TBL] [Abstract][Full Text] [Related]
15. RANKL coordinates cell cycle withdrawal and differentiation in osteoclasts through the cyclin-dependent kinase inhibitors p27KIP1 and p21CIP1.
Sankar U; Patel K; Rosol TJ; Ostrowski MC
J Bone Miner Res; 2004 Aug; 19(8):1339-48. PubMed ID: 15231022
[TBL] [Abstract][Full Text] [Related]
16. Regulation of T cell differentiation and alloimmunity by the cyclin-dependent kinase inhibitor p18ink4c.
Rowell EA; Wang L; Chunder N; Hancock WW; Wells AD
PLoS One; 2014; 9(3):e91587. PubMed ID: 24614758
[TBL] [Abstract][Full Text] [Related]
17. In CD28-costimulated human naïve CD4+ T cells, I-κB kinase controls the expression of cell cycle regulatory proteins via interleukin-2-independent mechanisms.
Lupino E; Buccinnà B; Ramondetti C; Lomartire A; De Marco G; Ricotti E; Tovo PA; Rinaudo MT; Piccinini M
Immunology; 2010 Oct; 131(2):231-41. PubMed ID: 20465575
[TBL] [Abstract][Full Text] [Related]
18. Limiting amounts of p27Kip1 correlates with constitutive activation of cyclin E-CDK2 complex in HTLV-I-transformed T-cells.
Cereseto A; Washington Parks R; Rivadeneira E; Franchini G
Oncogene; 1999 Apr; 18(15):2441-50. PubMed ID: 10229195
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of cell cycle progression by rapamycin induces T cell clonal anergy even in the presence of costimulation.
Powell JD; Lerner CG; Schwartz RH
J Immunol; 1999 Mar; 162(5):2775-84. PubMed ID: 10072524
[TBL] [Abstract][Full Text] [Related]
20. Defective cell cycle induction by IL-2 in naive T-cells antigen stimulated in the presence of refractory T-lymphocytes.
Inaba H; Geiger TL
Int Immunol; 2006 Jul; 18(7):1043-54. PubMed ID: 16702166
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
